HeXun Biosciences Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	264.9	200.99	257.67	119.74	85.03
Short-Term Investments	231.13	172	72	72	-
Cash & Short-Term Investments	496.03	372.99	329.67	191.74	85.03
Cash Growth	-	13.14%	71.94%	125.51%	-
Receivables	42.06	84.68	22.28	4.98	-
Inventory	9.84	15.58	4.6	-	-
Prepaid Expenses	10.56	8.33	6.85	9.44	8.37
Other Current Assets	10.18	1.67	0.27	5.08	0.01
Total Current Assets	568.67	483.25	363.67	211.24	93.4
Property, Plant & Equipment	141.35	139.1	113.93	94.27	102.83
Other Intangible Assets	21.49	26.67	34.26	41.23	1.75
Long-Term Deferred Tax Assets	1.57	1.57	-	-	-
Other Long-Term Assets	59.71	56.34	59.57	57.41	96.64
Total Assets	792.78	706.92	571.43	404.15	294.62
Accounts Payable	2.21	4.24	2.43	3.23	2.81
Accrued Expenses	12.38	19.16	9.65	3.21	1.42
Current Portion of Long-Term Debt	-	-	2.55	2.35	0.59
Current Portion of Leases	3.93	3.04	2.84	2.13	2.07
Current Income Taxes Payable	8.71	15.65	-	-	-
Current Unearned Revenue	17.12	8.7	1.73	3.6	-
Other Current Liabilities	11.05	2.97	10.98	5.51	0.93
Total Current Liabilities	55.39	53.76	30.17	20.03	7.83
Long-Term Debt	-	-	34.9	37.26	39.41
Long-Term Leases	33.62	31.98	32.32	29.9	32.03
Long-Term Unearned Revenue	-	-	-	1.5	-
Pension & Post-Retirement Benefits	-	-	0.08	-	-
Other Long-Term Liabilities	-	0.6	0.6	0.6	0.6
Total Liabilities	89.01	86.34	98.07	89.28	79.87
Common Stock	460	460	460	410	360
Additional Paid-In Capital	138.56	130.3	130.3	55.3	-
Retained Earnings	105.21	30.28	-116.95	-150.44	-145.25
Shareholders' Equity	703.77	620.58	473.36	314.87	214.75
Total Liabilities & Equity	792.78	706.92	571.43	404.15	294.62
Total Debt	37.55	35.02	72.61	71.64	74.1
Net Cash (Debt)	458.49	337.97	257.06	120.11	10.93
Net Cash Growth	-	31.47%	114.03%	999.17%	-
Net Cash Per Share	9.96	7.34	5.67	3.20	0.36
Filing Date Shares Outstanding	46	46	46	46	30.51
Total Common Shares Outstanding	46	46	46	41	30.51
Working Capital	513.28	429.49	333.5	191.22	85.58
Book Value Per Share	15.30	13.49	10.29	7.68	7.04
Tangible Book Value	682.28	593.91	439.09	273.64	213.01
Tangible Book Value Per Share	14.83	12.91	9.55	6.67	6.98
Machinery	127.82	118.95	82.49	63.57	63.23
Leasehold Improvements	31.33	29.82	28	21.69	20.92

Source: S&P Global Market Intelligence. Standard template. Financial Sources.